Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus

Buske, C.; Dreyling, M.; Alvarez-Larrán, A.; Apperley, J.; Arcaini, L.; Besson, C.; Bullinger, L.; Corradini, P.; Della Porta, M.G.; Dimopoulos, M.; D’Sa, S.; Eich, H.T.; Foà, R.; Ghia, P.; Gomes da Silva, M.; Gribben, J.; Hajek, R.; Harrison, C.; Heuser, M.; Kiesewetter, B.; Kiladjian, J.J.; Kröger, N.; Moreau, P.; Passweg, J.R.; Peyvandi, F.; Rea, D.; Ribera, J.M.; Robak, T.; San-Miguel, J.F.; Santini, V.; Sanz, G.; Sonneveld, P.; von Lilienfeld-Toal, M.; Wendtner, C.; Pentheroudakis, G.; Passamonti, F.

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus

Tools

Preview

PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
538kB

Item Type:	Article
Title:	Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus
Creators:	Buske, C., Dreyling, M., Alvarez-Larrán, A., Apperley, J., Arcaini, L., Besson, C., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Corradini, P., Della Porta, M.G., Dimopoulos, M., D’Sa, S., Eich, H.T., Foà, R., Ghia, P., Gomes da Silva, M., Gribben, J., Hajek, R., Harrison, C., Heuser, M., Kiesewetter, B., Kiladjian, J.J., Kröger, N., Moreau, P., Passweg, J.R., Peyvandi, F., Rea, D., Ribera, J.M., Robak, T., San-Miguel, J.F., Santini, V., Sanz, G., Sonneveld, P., von Lilienfeld-Toal, M., Wendtner, C., Pentheroudakis, G. and Passamonti, F.
Abstract:	BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies, raising questions about the optimal care of this patient group. METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of hematological malignancies in the Covid-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the Covid-19 diagnosis, treatment, and mitigation strategies to specific-HM management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.
Keywords:	COVID-19, Hematological Malignancies, Consensus Manuscript
Source:	ESMO Open
ISSN:	2059-7029
Publisher:	Elsevier
Volume:	7
Number:	2
Page Range:	100403
Date:	April 2022
Official Publication:	https://doi.org/10.1016/j.esmoop.2022.100403
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Downloads

Downloads per month over past year